Private Portfolio Partners LLC Pfizer Inc Transaction History

Private Portfolio Partners LLC

$122 Million
Q2 2024

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $134,809 - $154,804	5,207 Added 29.9%	22,619 $627,000
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $11,680 - $15,171	-447 Reduced 2.5%	17,412 $501,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $7,669 - $8,964	239 Added 1.36%	17,859 $592,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $25,356 - $29,336	702 Added 4.15%	17,620 $646,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $18,001 - $23,434	-457 Reduced 2.63%	16,918 $690,000
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $62,959 - $82,186	-1,508 Reduced 7.99%	17,375 $890,000
Q3 2022 Mar 14, 2023	SELL	$43.76 - $53.42 $30,238 - $36,913	-691 Reduced 3.53%	18,883 $826,000
Q3 2022 Nov 07, 2022	SELL	$43.76 - $53.42 $30,281 - $36,966	-692 Reduced 3.54%	18,883 $826,000
Q2 2022 Mar 14, 2023	SELL	$46.53 - $55.17 $65,560 - $77,734	-1,409 Reduced 6.71%	19,574 $1.03 Million
Q2 2022 Aug 02, 2022	SELL	$46.53 - $55.17 $65,514 - $77,679	-1,408 Reduced 6.71%	19,575 $1.03 Million
Q1 2022 Mar 14, 2023	BUY	$45.75 - $56.69 $73,794 - $91,440	1,613 Added 8.33%	20,983 $1.09 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $73,794 - $91,440	1,613 Added 8.33%	20,983 $1.09 Million
Q4 2021 Mar 14, 2023	BUY	$41.32 - $61.25 $7,313 - $10,841	177 Added 0.92%	19,370 $1.14 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $7,272 - $10,780	176 Added 0.92%	19,370 $1.14 Million
Q3 2021 Mar 14, 2023	BUY	$39.25 - $50.42 $181,413 - $233,041	4,622 Added 31.72%	19,193 $825,000
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $181,452 - $233,091	4,623 Added 31.73%	19,194 $826,000
Q2 2021 Mar 14, 2023	BUY	$35.91 - $40.68 $65,463 - $74,159	1,823 Added 14.3%	14,571 $570,000
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $65,428 - $74,118	1,822 Added 14.29%	14,571 $571,000
Q1 2021 Mar 14, 2023	SELL	$33.49 - $37.77 $4,085 - $4,607	-122 Reduced 0.95%	12,748 $461,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $4,052 - $4,570	-121 Reduced 0.94%	12,749 $462,000
Q4 2020 Mar 14, 2023	SELL	$33.47 - $42.56 $215,914 - $274,554	-6,451 Reduced 33.39%	12,870 $473,000
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $215,948 - $274,597	-6,452 Reduced 33.39%	12,870 $474,000
Q3 2020 Mar 14, 2023	BUY	$31.75 - $37.25 $61,785 - $72,488	1,946 Added 11.2%	19,321 $672,000
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $348,456 - $408,818	10,975 Added 131.48%	19,322 $709,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $111,504 - $135,271	-3,702 Reduced 30.72%	8,347 $273,000
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $18,839 - $26,918	697 Added 6.14%	12,049 $393,000
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $18,566 - $21,071	-564 Reduced 4.73%	11,352 $445,000
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $317,654 - $411,905	-9,777 Reduced 45.07%	11,916 $428,000
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $76,770 - $86,195	2,076 Added 10.58%	21,693 $939,000
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $25,087 - $27,562	669 Added 3.53%	19,617 $833,000
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $728,929 - $831,059	18,948 New	18,948 $827,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$15.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$12.6 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$8.51 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.93 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.48 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Portfolio Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Portfolio Partners LLC with notifications on news.

Account